| Literature DB >> 27567855 |
Ann Tiiman1, Jinghui Luo1,2, Cecilia Wallin1, Lisa Olsson1, Joel Lindgren3, Jϋri Jarvet1,4, Roos Per5,6, Sabrina B Sholts1,7, Shai Rahimipour8, Jan Pieter Abrahams9, Amelie Eriksson Karlström10, Astrid Gräslund1, Sebastian K T S Wärmländer1.
Abstract
Aggregation of the amyloid-beta (Aβ) peptide into insoluble plaques is a major factor in Alzheimer's disease (AD) pathology. Another major factor in AD is arguably metal ions, as metal dyshomeostasis is observed in AD patients, metal ions modulate Aβ aggregation, and AD plaques contain numerous metals including redox-active Cu and Fe ions. In vivo, Aβ is found in various cellular locations including membranes. So far, Cu(II)/Aβ interactions and ROS generation have not been investigated in a membrane environment. Here, we study Cu(II) and Zn(II) interactions with Aβ bound to SDS micelles or to engineered aggregation-inhibiting molecules (the cyclic peptide CP-2 and the ZAβ3(12-58)Y18L Affibody molecule). In all studied systems the Aβ N-terminal segment was found to be unbound, unstructured, and free to bind metal ions. In SDS micelles, Aβ was found to bind Cu(II) and Zn(II) with the same ligands and the same KD as in aqueous solution. ROS was generated in all Cu(II)/Aβ complexes. These results indicate that binding of Aβ to membranes, drugs, and other entities that do not interact with the Aβ N-terminal part, appears not to compromise the N-terminal segment's ability to bind metal ions, nor impede the capacity of N-terminally bound Cu(II) to generate ROS.Entities:
Keywords: Alzheimer’s disease; copper-binding protein; hydrogen peroxide; membrane zzm321990chemistry; neurodegeneration; protein aggregation
Mesh:
Substances:
Year: 2016 PMID: 27567855 DOI: 10.3233/JAD-160427
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472